(1)
Raloxifene in Reducing the Risk of Postmenopausal Fracture Amongst Osteoporotic Subjects. Int. Arch. Biomed. Clin. Res. 2024, 4 (3), 4-6. https://doi.org/10.21276/s6xhmj82.